Advertisement

Bipartisan plan to curb health premiums gets strong support

By Associated Press  |  October 20, 2017

Sens. Lamar Alexander's and Patty Murray's bill to resume paying cost-sharing subsidies to insurers has support from all 48 Democratic and independent senators, as well as 24 total co-sponsors from both parties. But its fate remains unclear as some Republicans seek changes that could threaten...

CMS may have overcorrected in cancellation of cardiac models

CMS may have overcorrected in cancellation of cardiac models

By Virgil Dickson  |  October 19, 2017

The CMS may have overcorrected when it honored some hospitals' requests to cancel mandatory cardiac pay models. The move means hospitals that were ready to embrace the models could be out millions of dollars.

Intermountain reorganizes its regions to form a 'model for tomorrow'

Intermountain reorganizes its regions to form a 'model for tomorrow'

By Alex Kacik  |  October 19, 2017

The Salt Lake City-based integrated health system is replacing its geographically defined administrative regions with a systemwide structure made up of community care and specialty care groups to better align internally to deliver more efficient and effective care, CEO Marc Harrison said.

Athenahealth to lay off more than 400 employees

Athenahealth to lay off more than 400 employees

By Rachel Z. Arndt  |  October 19, 2017

Athenahealth is shrinking its workforce by 9%, or more than 400 employees, as part of an "organizational redesign" to simplify the cloud-based EHR vendor's structure.

Software helps predict employee retention

Software helps predict employee retention

By Rachel Z. Arndt  |  October 19, 2017

Arena's job applicant screening platform helps healthcare organizations improve employee retention by algorithmically analyzing applicants' responses to assessments.

U.S. regulators approve second gene therapy for blood cancer

U.S. regulators approve second gene therapy for blood cancer

By Associated Press  |  October 19, 2017

Kite Pharma's newly approved blood cancer treatment, Yescarta, uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer can often evade.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print